Merrimack Axes 60 Of Workforce Explores Strategic Alternatives Halts Mm121 Development | Latest News RSS feed

Merrimack Axes 60 Of Workforce Explores Strategic Alternatives Halts Mm121 Development - Latest News


Merrimack Axes 60% of Workforce, Explores Strategic Alternatives, Halts MM-121 Development

Merrimack Pharmaceuticals says it will eliminate approximately 60% of its staff, explore strategic alternatives, and halt development of its lead candidate ... non-small cell lung cancer (NSCLC). The ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us